Rhinitis/Sinusitis/Upper Airway Diseases

Top Story

Clinicians welcome FDA’s approval of Pataday OTC

February 26, 2020
FDA News

FDA approves Dupixent for chronic rhinosinusitis with nasal polyps

June 26, 2019
The FDA approved Dupixent for use with other medicines to treat patients with chronic rhinosinusitis with nasal polyps, the agency, Regeneron Pharmaceuticals and Sanofi…
In the JournalsPerspective

Unique form of chronic rhinosinusitis identified in older patients

April 1, 2019
A unique inflammatory signature among older patients with chronic rhinosinusitis may make them less responsive to steroid treatment, according to findings recently…
Meeting News

Dupixent improves symptoms of severe chronic rhinosinusitis

March 12, 2019
Patients with severe chronic rhinosinusitis with nasal polyps treated with Dupixent showed improvements in nasal polyp size, nasal congestion severity, chronic sinus…
More Headlines »